Shawn Singh - 30 Jun 2025 Form 4 Insider Report for Vistagen Therapeutics, Inc. (VTGN)

Role: President and CEO, Director
Signature: /s/ Cynthia Anderson, Attorney-in-Fact
Issuer symbol: VTGN
Transactions as of: 30 Jun 2025
Net transactions value: +$12,820
Form type: 4
Filing time: 01 Jul 2025, 17:48:28 UTC
Previous filing: 25 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Singh Shawn	President and CEO, Director	C/O VISTAGEN THERAPEUTICS, INC., 343 ALLERTON AVENUE, SOUTH SAN FRANCISCO	/s/ Cynthia Anderson, Attorney-in-Fact	01 Jul 2025	0001412071

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VTGN	Common Stock	Award	$12,820	+7,541	+72%	$1.70	18,028	30 Jun 2025	Direct	F1
holding	VTGN	Common Stock						20,875	30 Jun 2025	By The 1997 Singh Family Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d).